In the original article, there was a mistake in Figure 1 as published. The dose of oral route FMT was mislabeled. The corrected Figure 1 appears below.
Figure 1
Study design timeline. The trial consisted of a 4-week period of FMT and an 8-week follow-up observation period after the end of treatment. The time schedule of sample collection and GI/behavioral assessments.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
gut microbiota, fecal microbiota transplantation, autism spectrum disorders, microbiome-gut-brain axis, clinic trial
Citation
Li N, Chen H, Cheng Y, Xu F, Ruan G, Ying S, Tang W, Chen L, Chen M, Lv L, Ping Y, Chen D and Wei Y (2021) Corrigendum: Fecal Microbiota Transplantation Relieves Gastrointestinal and Autism Symptoms by Improving the Gut Microbiota in an Open-Label Study. Front. Cell. Infect. Microbiol. 11:801376. doi: 10.3389/fcimb.2021.801376
Received
25 October 2021
Accepted
05 November 2021
Published
23 November 2021
Volume
11 - 2021
Edited and reviewed by
Tingtao Chen, Nanchang University, China
Updates
Copyright
© 2021 Li, Chen, Cheng, Xu, Ruan, Ying, Tang, Chen, Chen, Lv, Ping, Chen and Wei.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Dongfeng Chen, chendf1981@126.com; Yanling Wei, lingzi016@126.com
†These authors have contributed equally to this work
This article was submitted to Microbiome in Health and Disease, a section of the journal Frontiers in Cellular and Infection Microbiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.